Global Aurora Kinase B Market By Product Type (AZD-2811, CS-2164) And By End-Users/Application (Anaplastic Large Cell Lymphoma, Kidney Cancer) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984474
  • April 2021
  • Pharmaceuticals
  • 119 Pages

Report Preview

The Aurora Kinase B Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Aurora Kinase B Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Aurora Kinase B Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Aurora Kinase B market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Others
Applications Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, Sareum Holdings Plc
 
Aurora Kinase B Market Competitive and Premeditated Analysis
In the Aurora Kinase B report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Aurora Kinase B research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Aurora Kinase B Market Segmentation Analysis:
The Aurora Kinase B market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Others   

The application segment includes   Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Others

Major Key Players for Global Aurora Kinase B Market:
The Aurora Kinase B market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, Sareum Holdings Plc
 
The Aurora Kinase B market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Aurora Kinase B market:
The Aurora Kinase B market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Aurora Kinase B market:
By Type:
  • AZD-2811
  • CS-2164
  • Danusertib
  • Ilorasertib
  • NMI-900
  • Others

By Application
  • Anaplastic Large Cell Lymphoma
  • Kidney Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Aurora Kinase B report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Aurora Kinase B market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Aurora Kinase B market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Aurora Kinase B market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Aurora Kinase B market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Aurora Kinase B market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Aurora Kinase B market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Aurora Kinase B market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Aurora Kinase B market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Aurora Kinase B Market Snapshot
          2.1.1. Global Aurora Kinase B Market By Type,2019
               2.1.1.1.AZD-2811
               2.1.1.2.CS-2164
               2.1.1.3.Danusertib
               2.1.1.4.Ilorasertib
               2.1.1.5.NMI-900
               2.1.1.6.Others
          2.1.2. Global Aurora Kinase B Market By Application,2019
               2.1.2.1.Anaplastic Large Cell Lymphoma
               2.1.2.2.Kidney Cancer
               2.1.2.3.Lung Cancer
               2.1.2.4.Prostate Cancer
               2.1.2.5.Others
          2.1.3. Global Aurora Kinase B Market By End-use,2019
          2.1.4. Global Aurora Kinase B Market By Geography,2019

3. Global Aurora Kinase B Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Aurora Kinase B Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Aurora Kinase B Market Size (US$), By Type, 2018 – 2028

5. Global Aurora Kinase B Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Aurora Kinase B Market Size (US$), By Application, 2018 – 2028

6. Global Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028

7. Global Aurora Kinase B Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Aurora Kinase B Market Analysis, 2018 – 2028 
          7.2.1. North America Aurora Kinase B Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Aurora Kinase B Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Aurora Kinase B Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Aurora Kinase B Market Analysis, 2018 – 2028 
          7.3.1.  Europe Aurora Kinase B Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Aurora Kinase B Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Aurora Kinase B Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Aurora Kinase B Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Aurora Kinase B Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Aurora Kinase B Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Aurora Kinase B Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Aurora Kinase B Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Aurora Kinase B Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Aurora Kinase B Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Aurora Kinase B Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Aurora Kinase B Market Analysis, 2018 – 2028 
          7.6.1.  MEA Aurora Kinase B Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Aurora Kinase B Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Aurora Kinase B Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Aurora Kinase B Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Aurora Kinase B Providers
        8.4.1 AbbVie Inc
                8.1.1 Business Description
                8.1.2 AbbVie Inc Geographic Operations
                8.1.3 AbbVie Inc Financial Information
                8.1.4 AbbVie Inc Product Positions/Portfolio
                8.1.5 AbbVie Inc Key Developments
        8.4.2 Advenchen Laboratories LLC
                8.2.1 Business Description
                8.2.2 Advenchen Laboratories LLC Geographic Operations
                8.2.3 Advenchen Laboratories LLC Financial Information
                8.2.4 Advenchen Laboratories LLC Product Positions/Portfolio
                8.2.5 Advenchen Laboratories LLC Key Developments
        8.4.3 Aeterna Zentaris Inc
                8.3.1 Business Description
                8.3.2 Aeterna Zentaris Inc Geographic Operations
                8.3.3 Aeterna Zentaris Inc Financial Information
                8.3.4 Aeterna Zentaris Inc Product Positions/Portfolio
                8.3.5 Aeterna Zentaris Inc Key Developments
        8.4.4 Amgen Inc
                8.4.1 Business Description
                8.4.2 Amgen Inc Geographic Operations
                8.4.3 Amgen Inc Financial Information
                8.4.4 Amgen Inc Product Positions/Portfolio
                8.4.5 Amgen Inc Key Developments
        8.4.5 AstraZeneca Plc
                8.5.1 Business Description
                8.5.2 AstraZeneca Plc Geographic Operations
                8.5.3 AstraZeneca Plc Financial Information
                8.5.4 AstraZeneca Plc Product Positions/Portfolio
                8.5.5 AstraZeneca Plc Key Developments
        8.4.6 Chipscreen Biosciences Ltd
                8.6.1 Business Description
                8.6.2 Chipscreen Biosciences Ltd Geographic Operations
                8.6.3 Chipscreen Biosciences Ltd Financial Information
                8.6.4 Chipscreen Biosciences Ltd Product Positions/Portfolio
                8.6.5 Chipscreen Biosciences Ltd Key Developments
        8.4.7 Cielo Therapeutics Inc
                8.7.1 Business Description
                8.7.2 Cielo Therapeutics Inc Geographic Operations
                8.7.3 Cielo Therapeutics Inc Financial Information
                8.7.4 Cielo Therapeutics Inc Product Positions/Portfolio
                8.7.5 Cielo Therapeutics Inc Key Developments
        8.4.8 Sanofi
                8.8.1 Business Description
                8.8.2 Sanofi Geographic Operations
                8.8.3 Sanofi Financial Information
                8.8.4 Sanofi Product Positions/Portfolio
                8.8.5 Sanofi Key Developments
        8.4.9 Sareum Holdings Plc
                8.9.1 Business Description
                8.9.2 Sareum Holdings Plc Geographic Operations
                8.9.3 Sareum Holdings Plc Financial Information
                8.9.4 Sareum Holdings Plc Product Positions/Portfolio
                8.9.5 Sareum Holdings Plc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Aurora Kinase B Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Aurora Kinase B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Aurora Kinase B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Aurora Kinase B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Aurora Kinase B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Aurora Kinase B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Aurora Kinase B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Aurora Kinase B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Aurora Kinase B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Aurora Kinase B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Aurora Kinase B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Aurora Kinase B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Aurora Kinase B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Aurora Kinase B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Aurora Kinase B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Aurora Kinase B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Aurora Kinase B: Market Segmentation 
FIG. 2 Global Aurora Kinase B Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Aurora Kinase B Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Aurora Kinase B Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Aurora Kinase B Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Aurora Kinase B Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Aurora Kinase B Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Aurora Kinase B Providers, 2019
FIG. 11 Global Aurora Kinase B Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Aurora Kinase B Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Aurora Kinase B Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Aurora Kinase B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Aurora Kinase B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Aurora Kinase B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Aurora Kinase B Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Aurora Kinase B Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Aurora Kinase B market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Aurora Kinase B Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Aurora Kinase B Market Value, By Segment1, 2018 – 2028
TABLE  North America Aurora Kinase B Market Value, By Segment2, 2018 – 2028
TABLE  North America Aurora Kinase B Market Value, By Country, 2018 – 2028
TABLE  Europe Aurora Kinase B Market Value, By Segment1, 2018 – 2028
TABLE  Europe Aurora Kinase B Market Value, By Segment2, 2018 – 2028
TABLE  Europe Aurora Kinase B Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Aurora Kinase B Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Aurora Kinase B Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Aurora Kinase B Market Value, By Country, 2018 – 2028
TABLE  Latin America Aurora Kinase B Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Aurora Kinase B Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Aurora Kinase B Market Value, By Country, 2018 – 2028
TABLE  MEA Aurora Kinase B Market Value, By Segment1, 2018 – 2028
TABLE  MEA Aurora Kinase B Market Value, By Segment2, 2018 – 2028
TABLE  MEA Aurora Kinase B Market Value, By Country, 2018 – 2028
TABLE  AbbVie Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Advenchen Laboratories LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aeterna Zentaris Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chipscreen Biosciences Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cielo Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sareum Holdings Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Aurora Kinase B Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Aurora Kinase B Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Aurora Kinase B Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Aurora Kinase B Market, By Geography, 2019 (US$ Mn)
FIG.  Global Aurora Kinase B Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Aurora Kinase B Providers, 2016
FIG.  Global Aurora Kinase B Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global AZD-2811 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CS-2164 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Danusertib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ilorasertib Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NMI-900 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Aurora Kinase B Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Anaplastic Large Cell Lymphoma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Kidney Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Lung Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostate Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Aurora Kinase B Market Value, 2018 – 2028, (US$ Mn)